BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 18242716)

  • 1. Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis.
    Ju JH; Cho ML; Jhun JY; Park MJ; Oh HJ; Min SY; Cho YG; Hwang SY; Kwok SK; Seo SH; Yoon CH; Park SH; Kim HY
    Immunol Lett; 2008 Apr; 117(1):16-25. PubMed ID: 18242716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
    Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
    Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
    Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
    Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
    Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse.
    Mori H; Kitazawa R; Mizuki S; Nose M; Maeda S; Kitazawa S
    Histochem Cell Biol; 2002 Mar; 117(3):283-92. PubMed ID: 11914926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17.
    Yoshihara K; Yamada H; Hori A; Yajima T; Kubo C; Yoshikai Y
    Eur J Immunol; 2007 Oct; 37(10):2744-52. PubMed ID: 17823984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8alpha+ dendritic cells enhance the antigen-specific CD4+ T-cell response and accelerate development of collagen-induced arthritis.
    Jung YO; Min SY; Cho ML; Park MJ; Jeon JY; Lee JS; Oh HJ; Kang CM; Park HS; Park KS; Cho SG; Park SH; Kim HY
    Immunol Lett; 2007 Aug; 111(2):76-83. PubMed ID: 17610959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
    Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
    Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
    Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
    Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
    Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
    Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis.
    Tada Y; Ho A; Koh DR; Mak TW
    J Immunol; 1996 Jun; 156(11):4520-6. PubMed ID: 8666829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
    Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
    J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.